Healio (11/5, Gramigna) reported, “Estimating treatment effects on caregivers can help determine the cost-effectiveness of treatments for Alzheimer’s disease, according to results of an economic evaluation.” For the research, published in JAMA Network Open, investigators “sought to examine how inclusion of various patient, caregiver and societal treatment-related factors altered cost-effectiveness estimates of a hypothetical disease-modifying AD treatment.” (SOURCE: APA Headlines)